Penny Stock Under Rs 100: This Pharma Company Soars Over 12% After Launching ‘FOLIMAN’ Folic Acid Tablets
Shelter Pharma Ltd share price surged over 12 per cent after the launch of ‘FOLIMAN’ Folic Acid Tablets.
✨ AI Powered Summary
Shelter Pharma Ltd share price rallied more than 12 per cent in Intraday trade on May 11, 2026, after the company announced the launch of a new healthcare product, ‘FOLIMAN’ Folic Acid Tablets, aimed at strengthening its presence in the healthcare and nutraceutical segment.
In an exchange filing, the company informed that the newly launched product is a Vitamin B-9 supplement developed as part of its ongoing efforts to expand its healthcare and nutraceutical product portfolio. The company stated that the product launch aligns with its broader long-term expansion strategy and is expected to create additional business growth opportunities.
According to the filing, the product is initially being introduced in the international market. The company also indicated that it may subsequently launch the product in the domestic market in due course, depending on market opportunities and business requirements.
About Shelter Pharma Ltd
Shelter Pharma Ltd is a Gujarat-based healthcare company with a legacy of nearly 60 years in the natural remedies and wellness segment. Headquartered in Himmatnagar, Gujarat, the Company focuses on offering Ayurvedic and Unani healthcare products aimed at promoting healthy living. Shelter Pharma was founded in 1965 by Mr. N. R. Gandhi, a renowned practitioner of Ayurveda and Unani systems of medicine.
Shelter Pharma Ltd Share Price Performance
Shelter Pharma Ltd share price delivered a strong performance on May 11, 2026, with the stock rising 12.23 per cent to close at Rs 33.68, up Rs 3.67 from the previous session. The stock witnessed robust buying interest during the trading session and touched an intraday high of Rs 33.70, while the day’s low stood at Rs 31.79.
Disclaimer: The article is for informational purposes only and not investment advice.
